Eurogenerics

Company number 0419.806.694

Track this competitor Create a free account to be notified when it wins a contract.

Contracts won: 15
Amount won alone: €13,255,607 excl. VAT
Shared contracts: 6 (multi-supplier framework agreements)
Period: 8 January 2024 – 12 January 2026

Its main clients

AZ Sint-Jan Brugge AV · 3 contracts
AZ Delta vzw · 3 contracts
UZ Leuven · 3 contracts
HUmani SC · 2 contracts
EMMAUS VZW · 1 contract
VITAZ vzw · 1 contract
Association iris-Achats · 1 contract
Hospilim VZW · 1 contract

Where and what

Supplies · 15

West Flanders · 6 Flemish Brabant · 3 Hainaut · 2 Antwerp · 1 East Flanders · 1 Brussels-Capital · 1 Limburg · 1

Its contracts coming to an end

So many opportunities to take over these contracts when they are re-tendered.

Planned end	Contract	Current holder	Amount
20 December 2026 re-tender around October 2026	leveren van Ranibizumab voor intra-oculair gebruik UZ Leuven framework agreement	EUROGENERICS SA 3 bids received	€7,053,720
10 March 2027 re-tender around October 2026	LEVERING ONDANSETRON (smelt)tabletten en inspuitbaar 4 mg - 8 mg UZ Leuven	Fresenius Kabi EUROGENERICS SA sandoz 6 bids received	€255,489
14 October 2027 re-tender around April 2027	Raamovereenkomst voor aankoop van Paclitaxel Albumine-gebonden Nanodeeltjes AZ Sint-Jan Brugge AV framework agreement	Eurogenerics 1 bid received	€500,000
1 December 2027 re-tender around June 2027	Fourniture 'd'anastroazole, anagrelide, letrozole, bevacizumab, bortezomib et de fulvestrant 2023-2027 HUmani SC framework agreement	Arega Pharma BV Celltrion Healthcare Netherlands BV Eurogenerics Pharmanovia Benelux B.V. 7 bids received	€832,552
4 December 2027 re-tender around June 2027	Fourniture de sugammadex 2023-2027 HUmani SC framework agreement	Eurogenerics 6 bids received	€343,824
20 December 2027 re-tender around June 2027	Spécialité pharmaceutique à base de Sugammadex Association iris-Achats	EUROGENERICS 4 bids received	€295,240
5 August 2028 re-tender around February 2028	Ranibizumab AZ Delta vzw framework agreement	Eurogenerics NV 3 bids received	€1,383,840
15 December 2028 re-tender around June 2028	Bosutinib AZ Delta vzw framework agreement	Eurogenerics NV 1 bid received	€361,679
12 April 2029 re-tender around October 2028	Diverse geneesmiddelen oncologie PO voor Helixziekenhuizen EMMAUS VZW framework agreement	EUROGENERICS SA Novartis Pharma PFIZER SA Accord Healthcare BV SANDOZ NV AREGA PHARMA BVBA Mylan EPD (Entiteit van Viatris) 4 bids received	€874,780
10 August 2029 re-tender around February 2029	Fingolimod AZ Delta vzw framework agreement	Eurogenerics NV 1 bid received	€871,104

Contracts won

Date	Contract	Buyer	Amount
12/01/2026	Raamovereenkomst voor aankoop van Paclitaxel Albumine-gebonden Nanodeeltjes	AZ Sint-Jan Brugge AV	€500,000
17/07/2025	Fingolimod	AZ Delta vzw	€871,104
04/06/2025	Diverse geneesmiddelen oncologie PO voor Helixziekenhuizen	EMMAUS VZW	€874,780 shared by 7
04/04/2025	LEVERING ONDANSETRON (smelt)tabletten en inspuitbaar 4 mg - 8 mg	UZ Leuven	€255,489 shared by 3
27/12/2024	leveren van Ranibizumab voor intra-oculair gebruik	UZ Leuven	€7,053,720
11/12/2024	Bosutinib	AZ Delta vzw	€361,679
18/11/2024	Zoledroninezuur	UZ Leuven	€1,400,107 shared by 2
10/09/2024	Ranibizumab	AZ Delta vzw	€1,383,840
29/04/2024	Raamovereenkomst voor leveren van Cytostatica geneesmiddelen	AZ Sint-Jan Brugge AV	€3,379,003 shared by 10
05/04/2024	Ranibizumab	VITAZ vzw	€1,096,200
18/03/2024	Raamovereenkomst voor aankoop Ranibizumab	AZ Sint-Jan Brugge AV	€1,350,000
12/01/2024	Fourniture 'd'anastroazole, anagrelide, letrozole, bevacizumab, bortezomib et de fulvestrant 2023-2027	HUmani SC	€832,552 shared by 4
12/01/2024	Fourniture de sugammadex 2023-2027	HUmani SC	€343,824
09/01/2024	Spécialité pharmaceutique à base de Sugammadex	Association iris-Achats	€295,240
08/01/2024	Raamovereenkomst voor de levering van psychofarmaca	Hospilim VZW	€2,719,170 shared by 5

Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.